Ann Surg Oncol (2017) 24:2447–2455 DOI 10.1245/s10434-017-5887-2 O R I G IN AL ARTI CL E – HE PA TOBILI ARY T U M O R S LiMAx Test Improves Diagnosis of Chemotherapy-Associated Liver Injury Before Resection of Colorectal Liver Metastases 1 2 2 3 3 Johan F. Lock, MD , Tilman Westphal, MD , Tom Rubin, PhD , Maciej Malinowski, MD , Antje Schulz, MD , 2 4 2,5 Maximilian Jara, MD , Jan Bednarsch, MD , and Martin Stockmann, MD, PhD Department of General, Visceral, Vascular and Paediatric Surgery, University Hospital of Wu ¨ rzburg, Wu ¨ rzburg, Germany; Department of General, Visceral and Transplantation Surgery, Charite -Universita ¨tsmedizin Berlin, Berlin, Germany; Department of General, Visceral, Vascular and Pediatric Surgery, Saarland University Hospital, Homburg (Saar), Germany; Department of General, Visceral and Transplantation Surgery, University Hospital Aachen, Rhine Westphalia Institute of Technology, Aachen, Germany; Evangelisches Krankenhaus Paul Gerhardt Stift, Lutherstadt Wittenberg, Germany ABSTRACT chemotherapy, and no effects of chemotherapy, liver Background. Chemotherapy of colorectal liver metastases steatosis or ﬁbrosis on biochemical parameters were (CLMs) prior to liver resection implies the risk of observed. LiMAx impairment was dependent on the num- chemotherapy-associated liver injury, leading to increased ber of
Annals of Surgical Oncology – Springer Journals
Published: May 17, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera